DIGITALLOOK |
FTSE 250 movers: Indivior surges on FDA drug recommendation; Royal Mail weak again
DIGITALLOOK On the downside, Royal Mail was in the red for the second day running after Credit Suisse downgraded the stock on Tuesday to 'underperform' from 'neutral'. The bank said it expects worsening letter revenue trends and a costly labour deal to render 2018 … |
More: continued here